Advances in the development of new vaccines against tuberculosis. 100 years after the introduction of BCG

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2014, Vol 68, Issue

Abstract

The BCG vaccine used in the world for nearly 100 years protects children against the most severe forms of tuberculosis, but its effectiveness in preventing the most commonly occurring tuberculosis and the one burdened with the highest risk of transmission in adults is very diverse. Contraindications for BCG vaccination include HIV infection and other conditions of immunosuppression. Tuberculosis is a global problem difficult to control because of three main reasons: poor diagnostics in developing countries, long-term therapy or discontinuation of treatment resulting in the emergence of drug-resistant mycobacteria, and the availability of a TB vaccine which only protects children from the most severe forms of tuberculosis. BCG has little to no efficacy in preventing the most common adult pulmonary TB. The development of a more effective vaccine against tuberculosis is undoubtedly still a public health priority in order to improve control of the disease throughout the world. Elimination of TB as a global public health goal by 2050 is particularly ambitious and its achievement depends on the development and application of new intervention measures and newly designed vaccines. Currently, 14 newly developed products are undergoing clinical trials. These include a prophylactic vaccine capable of replacing the current BCG, booster vaccines to increase the effects of BCG, and therapeutic vaccines. The aim of the study is to present the current state of knowledge on cutting-edge research into new vaccines against tuberculosis, their efficacy, immunogenicity and potential use in the future.

Authors and Affiliations

Katarzyna Krysztopa-Grzybowska, Anna Lutyńska

Keywords

Related Articles

Chirurgiczne wycięcie rozległych kłykcin kończystych odbytu jest operacją nie powodującą ryzyka zwężenia odbytu

Wstęp: Kłykciny kończyste odbytu były już dobrze znaną chorobą w starożytności, ale w ostatnich latach obserwuje się szybki wzrost liczby osób cierpiących na tę chorobę. Główną przyczyną tej choroby jest zakażenie wirus...

The role of biological sciences in understanding the genesis and a new therapeutic approach to Alzheimer’s disease

The paper contrasts the historical view on causal factors in Alzheimer’s disease (AD) with the modern concept of the symptoms’ origin. Biological sciences dealing with cell structure and physiology enabled comprehensio...

Multilevel maturation of Toll-like receptor 9

Toll-like receptors (TLRs) are essential elements of the innate immune response. TLRs induce expression of inflammatory cytokines or interferons after recognition of microbial or viral structures called pathogen-associat...

Dehydrogenaza alkoholowa – znaczenie fizjologiczne i diagnostyczne

Dehydrogenaza alkoholowa (ADH) jest polimorficznym enzymem, występującym w postaci kilkunastu izoenzymów podzielonych na kilka klas, umiejscowionych w różnych narządach. ADH odgrywa znaczącą rolę w metabolizmie wielu waż...

Infection cases in infants and small children with atopic dermatitis – own observations

Introduction: The purpose of the work is to estimate the frequency of occurrence of various infections in infants and small children, aged between 0 and 36 months with atopic dermatitis in the practice of a family doctor...

Download PDF file
  • EP ID EP67409
  • DOI -
  • Views 117
  • Downloads 0

How To Cite

Katarzyna Krysztopa-Grzybowska, Anna Lutyńska (2014). Advances in the development of new vaccines against tuberculosis. 100 years after the introduction of BCG. Advances in Hygiene and Experimental Medicine, 68(), 768-776. https://europub.co.uk/articles/-A-67409